Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/12/1992 | EP0498590A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
08/12/1992 | EP0498588A1 Use of tenidap to reduce total serum cholesterol, LDL cholesterol and triglycerides |
08/12/1992 | EP0498471A2 Liposomes comprising a guanidino aminoglycoside |
08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
08/12/1992 | EP0498468A1 Device for transcutaneous application of nicotine |
08/12/1992 | EP0498466A1 Indazole-3-carboxamide and -3-carboxylic acid derivatives |
08/12/1992 | EP0498372A1 Sustained-release pranoprofen preparation |
08/12/1992 | EP0498334A1 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines |
08/12/1992 | EP0498331A1 N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3.2.1)octanes, intermediates and a process for the preparation thereof and their use as medicaments |
08/12/1992 | EP0498290A1 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection |
08/12/1992 | EP0498272A1 Effervescent bathing preparation |
08/12/1992 | EP0498144A1 Use of acetyl L-carnitine in the therapeutic treatment of coma |
08/12/1992 | EP0498095A1 Sulfonic stilbene derivatives in the treatment of viral diseases |
08/12/1992 | EP0498011A1 Salts of the 2-(2,6-dichloroanilino)-phenylacetic acid, process for their preparation and their application as pharmaceutical preparations for topical use |
08/12/1992 | EP0497997A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
08/12/1992 | EP0497988A1 Antiviral agent |
08/12/1992 | EP0497978A1 Cephalosporin compounds and production thereof |
08/12/1992 | EP0497952A1 Composition for the topical treatment of psoriasis |
08/12/1992 | EP0497910A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
08/12/1992 | EP0497895A1 Method of inhibiting the transport of l-glutamate |
08/12/1992 | EP0497888A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla 2? and lipoxygenase |
08/12/1992 | EP0497875A1 2' modified oligonucleotides |
08/12/1992 | EP0497845A1 Bafilomycine macrolides for treatment of bone affecting diseases |
08/12/1992 | EP0497835A1 Method for treating hiv and other retroviruses and compounds useful therefor |
08/12/1992 | EP0497834A1 Carnitine supplemented cat fish diet |
08/12/1992 | EP0497816A1 Treatment of hiv infections and compounds useful therein. |
08/12/1992 | EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
08/12/1992 | EP0497756A1 Antithrombotic composition. |
08/12/1992 | EP0494256A4 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
08/12/1992 | EP0490916A4 Compositions and methods of manufacture of oral dissolvable medicaments |
08/12/1992 | EP0375689B1 A pharmaceutical composition adapted for transdermal delivery of an opoid drug. |
08/12/1992 | EP0313617B1 Lipid emulsion and method for intravenous infusion |
08/12/1992 | EP0201575B1 New picoline derivatives, preparation process thereof, utilization thereof and drugs containing them |
08/12/1992 | CN1063491A 1,4-benzothiazepine derivatives |
08/12/1992 | CN1063489A Process for preparation of substituted benzotetrahydropyridine and related compounds |
08/12/1992 | CN1063486A Deacetylcolchicine derivatives |
08/12/1992 | CN1063485A Process for preparation of 72-78 percent solution of sodium lactate |
08/12/1992 | CN1063415A Methods for preparing alleviating menopausal symptoms |
08/12/1992 | CN1017802B Method for preparing 6-(substd.) hydroxymethyl-penicillanic acids or 1,1-dioxide and derivs thereof |
08/12/1992 | CN1017801B Method for preparing 6-(substd) hydroxymethyl-penicillanic acids or 1, 1-dioxide and derivs,thereof |
08/12/1992 | CN1017800B Tricyclic compounds |
08/12/1992 | CA2060967A1 N-myristoyltransferase inhibitors, process for their preparation and pharmaceutical compositions containing them |
08/12/1992 | CA2060949A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
08/12/1992 | CA2060945A1 Pyridine compounds |
08/12/1992 | CA2060940A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydro-naphthalenes and chromans |
08/12/1992 | CA2060107A1 Nitrogen heterocycles |
08/12/1992 | CA2060050A1 Heterocyclic derivatives |
08/11/1992 | US5138091 Chemical intermediate |
08/11/1992 | US5138090 Substituted biphenyls |
08/11/1992 | US5138064 Chemical intermediate for penicillin derivative |
08/11/1992 | US5138060 Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
08/11/1992 | US5138059 Dc-89 compounds and process for their preparation |
08/11/1992 | US5138058 Piperazine substituted pyrimidine derivatives and physiologically tolerated salts thereof |
08/11/1992 | US5138049 Cephalosporin derivative |
08/11/1992 | US5138048 Bactericide |
08/11/1992 | US5138045 Polyamine conjugated oligonucleotides |
08/11/1992 | US5137928 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
08/11/1992 | US5137923 Lipophilic quaternary ammonium salicylates, their use in cosmetics and in dermopharmacy |
08/11/1992 | US5137922 Method for inhibiting and treating infection caused by influenza virus |
08/11/1992 | US5137921 Conduritol A, a monosaccharide; affects intestinal absorption |
08/11/1992 | US5137920 Method of treating fungal infections |
08/11/1992 | US5137918 Anticancer agent |
08/11/1992 | US5137917 Immunopotentiators; administering to mammals |
08/11/1992 | US5137916 Prevents, food spoilage, protein aging in animals |
08/11/1992 | US5137915 Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
08/11/1992 | US5137914 Vasodilation, anticoagulants, bronchodilator agents |
08/11/1992 | US5137913 Diaryl ether cyclic ethers |
08/11/1992 | US5137912 Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug |
08/11/1992 | US5137911 Isochromane derivatives |
08/11/1992 | US5137910 Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders |
08/11/1992 | US5137909 Indole derivative and method of production thereof |
08/11/1992 | US5137906 Treatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonists |
08/11/1992 | US5137905 Cholinergic agonists; analgesics; cognition activators |
08/11/1992 | US5137902 4-alkylimidazole derivatives and anti-hypertensive use thereof |
08/11/1992 | US5137901 For binding 5-HT 1 receptors; treating central nervous system disorders |
08/11/1992 | US5137900 Antagonists of cholecystokinin and gastrin, antabiotic, analgasic, antiulcer, antitumor and for treatment of gastro intestinal and central nervous system disorders |
08/11/1992 | US5137897 Nonsteroidal antiinflammatory agents; therapy for rheumatic diseases |
08/11/1992 | US5137894 Psychological disorders |
08/11/1992 | US5137892 Quinoline, naphthyridine and pyridobenzoxazine derivatives |
08/11/1992 | US5137891 2',3' cyclic fused pyrazolopyrimidine type mevalonolactones |
08/11/1992 | US5137889 Dihydropyridine derivatives and process for preparing the same |
08/11/1992 | US5137887 Salts of optically active 4-hydroxy-8(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo(1,5-a)-1,3,5- triazines and a process for production thereof |
08/11/1992 | US5137885 Inotropic agents; vasodilators |
08/11/1992 | US5137882 Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
08/11/1992 | US5137881 Anticholesterol, antilipemic agents |
08/11/1992 | US5137878 Composition and method for treatment of senile dementia |
08/11/1992 | US5137877 Bifunctional linking compounds, conjugates and methods for their production |
08/11/1992 | US5137876 Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same |
08/11/1992 | US5137734 Administering to stimulate wound healing and neovascularization |
08/11/1992 | US5137732 Riboflavin granules containing no inactive ingredient |
08/11/1992 | US5137730 Tablet composition and method for problem pharmaceutical materials using citric acid |
08/11/1992 | US5137724 Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines |
08/11/1992 | US5137723 α-Glycosyl-L-ascorbic acid, and its preparation and uses |
08/11/1992 | US5137722 Extract and pharmaceutical composition for treatment of calcium oxalate stone disease |
08/11/1992 | US5137718 Infection fighting composition for topical application |
08/11/1992 | US5137716 Orally administering dietetic composition consists of cholestyramine, bran and optionally, artificial sweetneres and flavors |
08/11/1992 | US5137714 Anhydrous cosmetic composition comprising stable lower alkyl esters of pyroglutamic acid |
08/11/1992 | US5137712 Use of s-adenosyl-l-methionine (SAMe) to reverse and/or prevent supersensitivity, tolerance and extrapyramidal side effects induced by neuroleptic treatment |
08/11/1992 | CA1306262C2 1,4-dihydropyridines, a process for their preparation and their application as medecines |
08/11/1992 | CA1306261C 1,4-dihydropyridines, a process for their preparation and their use as a medecine |